These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 30426359)

  • 21. Characterization of the muscle involvement in dynamin 2-related centronuclear myopathy.
    Fischer D; Herasse M; Bitoun M; Barragán-Campos HM; Chiras J; Laforêt P; Fardeau M; Eymard B; Guicheney P; Romero NB
    Brain; 2006 Jun; 129(Pt 6):1463-9. PubMed ID: 16585051
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinicopathological features of centronuclear myopathy in Japanese populations harboring mutations in dynamin 2.
    Mori-Yoshimura M; Okuma A; Oya Y; Fujimura-Kiyono C; Nakajima H; Matsuura K; Takemura A; Malicdan MC; Hayashi YK; Nonaka I; Murata M; Nishino I
    Clin Neurol Neurosurg; 2012 Jul; 114(6):678-83. PubMed ID: 22613877
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A novel mutation in the dynamin 2 gene in a Charcot-Marie-Tooth type 2 patient: clinical and pathological findings.
    Bitoun M; Stojkovic T; Prudhon B; Maurage CA; Latour P; Vermersch P; Guicheney P
    Neuromuscul Disord; 2008 Apr; 18(4):334-8. PubMed ID: 18394888
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dynamin 2 and human diseases.
    Durieux AC; Prudhon B; Guicheney P; Bitoun M
    J Mol Med (Berl); 2010 Apr; 88(4):339-50. PubMed ID: 20127478
    [TBL] [Abstract][Full Text] [Related]  

  • 25. BIN1 modulation in vivo rescues dynamin-related myopathy.
    Lionello VM; Kretz C; Edelweiss E; Crucifix C; Gómez-Oca R; Messaddeq N; Buono S; Koebel P; Massana Muñoz X; Diedhiou N; Cowling BS; Bitoun M; Laporte J
    Proc Natl Acad Sci U S A; 2022 Mar; 119(9):. PubMed ID: 35217605
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reducing dynamin 2 expression rescues X-linked centronuclear myopathy.
    Cowling BS; Chevremont T; Prokic I; Kretz C; Ferry A; Coirault C; Koutsopoulos O; Laugel V; Romero NB; Laporte J
    J Clin Invest; 2014 Mar; 124(3):1350-63. PubMed ID: 24569376
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Two novel mutations in dynamin-2 cause axonal Charcot-Marie-Tooth disease.
    Fabrizi GM; Ferrarini M; Cavallaro T; Cabrini I; Cerini R; Bertolasi L; Rizzuto N
    Neurology; 2007 Jul; 69(3):291-5. PubMed ID: 17636067
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mutant BIN1-Dynamin 2 complexes dysregulate membrane remodeling in the pathogenesis of centronuclear myopathy.
    Fujise K; Okubo M; Abe T; Yamada H; Nishino I; Noguchi S; Takei K; Takeda T
    J Biol Chem; 2021; 296():100077. PubMed ID: 33187981
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Physiological impact and disease reversion for the severe form of centronuclear myopathy linked to dynamin.
    Massana Muñoz X; Kretz C; Silva-Rojas R; Ochala J; Menuet A; Romero NB; Cowling BS; Laporte J
    JCI Insight; 2020 Sep; 5(18):. PubMed ID: 32809972
    [TBL] [Abstract][Full Text] [Related]  

  • 30. DNM2 levels normalization improves muscle phenotypes of a novel mouse model for moderate centronuclear myopathy.
    de Carvalho Neves J; Moschovaki-Filippidou F; Böhm J; Laporte J
    Mol Ther Nucleic Acids; 2023 Sep; 33():321-334. PubMed ID: 37547294
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A centronuclear myopathy-causing mutation in dynamin-2 disrupts neuronal morphology and excitatory synaptic transmission in a murine model of the disease.
    Arriagada-Diaz J; Flores-Muñoz C; Gómez-Soto B; Labraña-Allende M; Mattar-Araos M; Prado-Vega L; Hinostroza F; Gajardo I; Guerra-Fernández MJ; Bevilacqua JA; Cárdenas AM; Bitoun M; Ardiles AO; Gonzalez-Jamett AM
    Neuropathol Appl Neurobiol; 2023 Aug; 49(4):e12918. PubMed ID: 37317811
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neuromuscular junction abnormalities in DNM2-related centronuclear myopathy.
    Gibbs EM; Clarke NF; Rose K; Oates EC; Webster R; Feldman EL; Dowling JJ
    J Mol Med (Berl); 2013 Jun; 91(6):727-37. PubMed ID: 23338057
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A new mutation in DNM2 gene in a large Italian family.
    Lopergolo D; Bocci S; Pinto AM; Valentino F; Doddato G; Ginanneschi F; Volpi N; Renieri A; Giannini F
    Neurol Sci; 2021 Jun; 42(6):2509-2513. PubMed ID: 33459893
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dynamins in human diseases: differential requirement of dynamin activity in distinct tissues.
    Laiman J; Lin SS; Liu YW
    Curr Opin Cell Biol; 2023 Apr; 81():102174. PubMed ID: 37230036
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical, pathological, and genetic features of dynamin-2-related centronuclear myopathy in China.
    Chen T; Pu C; Wang Q; Liu J; Mao Y; Shi Q
    Neurol Sci; 2015 May; 36(5):735-41. PubMed ID: 25501959
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Imaging-based evaluation of pathogenicity by novel DNM2 variants associated with centronuclear myopathy.
    Fujise K; Okubo M; Abe T; Yamada H; Takei K; Nishino I; Takeda T; Noguchi S
    Hum Mutat; 2022 Feb; 43(2):169-179. PubMed ID: 34837441
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mutational and clinical spectrum of centronuclear myopathy in 9 cases and a literature review of Chinese patients.
    Wang Q; Yu M; Xie Z; Liu J; Wang Q; Lv H; Zhang W; Yuan Y; Wang Z
    Neurol Sci; 2022 Apr; 43(4):2803-2811. PubMed ID: 34595679
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization and genetic diagnosis of centronuclear myopathies in seven Chinese patients.
    Zhao Y; Zhao Z; Shen H; Bing Q; Hu J
    Neurol Sci; 2018 Dec; 39(12):2043-2051. PubMed ID: 30232666
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Satellite cells deficiency and defective regeneration in dynamin 2-related centronuclear myopathy.
    F Almeida C; Bitoun M; Vainzof M
    FASEB J; 2021 Apr; 35(4):e21346. PubMed ID: 33715228
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dynamin-2 mutations associated with centronuclear myopathy are hypermorphic and lead to T-tubule fragmentation.
    Chin YH; Lee A; Kan HW; Laiman J; Chuang MC; Hsieh ST; Liu YW
    Hum Mol Genet; 2015 Oct; 24(19):5542-54. PubMed ID: 26199319
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.